Valeant Pharmaceuticals (VRX)

Add to Watchlists
Create an Alert
122.05 +0.60  +0.49% NYSE Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
VRX Price Chart
View All Events

VRX Events

Date Type Description
Feb 27 Misc Valeant Pharmaceuticals International Inc Q4 2013 Earnings Conference Call
Feb 27 Earnings Valeant Pharmaceuticals International Inc Q4 2013 Earnings Results. Estimate: 2.06.
Feb 03 Misc Valeant Pharmaceuticals to Acquire Precision Dermatology for $475 Million
Jan 23 Misc Valeant Pharmaceuticals International, Inc. Completes Acquisition of Solta Medical, Inc.
Oct 31 Misc Q3 2013 Valeant Pharmaceuticals International, Inc. Earnings Conference Call
Oct 31 Earnings Valeant Pharmaceuticals to Announce 2013 Third Quarter Results on October 31, 2013. Estimate: 1.40.
Aug 07 Misc Valeant Pharmaceuticals to Announce 2013 Second Quarter Results and Conference Call on August 7, 2013
Aug 07 Earnings Valeant Pharmaceuticals to Announce 2013 Second Quarter Results on August 7, 2013. Estimate: 1.29.
Aug 06 Misc Valeant Pharmaceuticals International, Inc. Completes Acquisition of Bausch + Lomb
May 21 Misc AGM Event for Valeant Pharmaceuticals International Inc
View All Performance Charts

VRX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Valeant Pharmaceuticals is up 67.51% over the last year vs S&P 500 Total Return up 23.54%, Forest Laboratories up 151.7%, and Jazz Pharmaceuticals up 148.9%.

Get Quote for

PDF Report for VRX

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download VRX Pro Report PDF

Portfolio Strategies Featuring VRX

Did Valeant Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

VRX Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Headquarters Country: Canada
  • Headquarters State/Province: Quebec
  • Incorporation Country: Canada
  • Incorporation State/Province: N/A
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A

Valeant Pharmaceuticals International, Inc. is a pharmaceutical company with activities spanning the drug discovery pipeline from target identification through clinical trials and commercialization. The focus of the company is on neurology, dermatology and infectious disease with several drugs in late-stage clinical trials and several currently on the market. In addition, Valeant has a portfolio of more than 500 products from its prior history as a group of speciality chemical and radiochemical research, development and supply companies with a history stretching back to the 1960s. Kinerase, used kinetin as active entity is one of the most famous product of this company. The company was formerly known as Biovail Corporation and changed its name to Valeant Pharmaceuticals International, Inc. in September 2010. The company is headquartered in Mississauga, Canada.

Recent Quotes

Symbol Price Chg Chg % Market Cap
VRX 122.05 +0.60 +0.49% 40.87B
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.